Erectile dysfunction and cardiovascular risk: a review of current findings

Expert Rev Cardiovasc Ther. 2020 Mar;18(3):155-164. doi: 10.1080/14779072.2020.1745632. Epub 2020 Apr 3.

Abstract

Introduction: A large body of evidence has clearly documented that erectile dysfunction (ED) represents not only a complication of cardiovascular (CV) diseases (CVD) but often an early sign of forthcoming CVD.Areas covered: All the available data from meta-analyses evaluating the association between ED and CV risk were collected and discussed. Similarly, all available meta-analyses investigating the significance of ED as a possible early marker for major adverse cardiovascular events (MACE) were analyzed. In addition, data originally obtained in a Florence cohort, dealing with a large series of patients seeking medical care for sexual dysfunction, will be also reported.Expert opinion: Available evidence indicates that ED represents a risk factor of CV mortality and morbidity. Not only conventional CV risk factors but also unconventional ones, derived from a perturbation of the relational and intrapsychic domains of ED, might play a possible role in CV risk stratification of ED subjects. Finally, penile doppler ultrasound can give important information on CV risk, especially in younger and low risk subjects. The presence of ED should become an opportunity - for the patient and for the physician - to screen for the presence of comorbidities improving not only sexual health but, more importantly, men's overall health.

Keywords: Erectile dysfunction; MACE; cardiovascular risk; hypoactive sexual desire; penile doppler ultrasound.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular System / physiopathology
  • Erectile Dysfunction / physiopathology*
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Penis / blood supply*
  • Penis / diagnostic imaging
  • Risk Factors

Substances

  • Biomarkers